MYELOID OR LYMPHOID NEOPLASMS (MLN)

Clinical trials for MYELOID OR LYMPHOID NEOPLASMS (MLN) explained in plain language.

Never miss a new study

Get alerted when new MYELOID OR LYMPHOID NEOPLASMS (MLN) trials appear

Sign up with your email to follow new studies for MYELOID OR LYMPHOID NEOPLASMS (MLN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Targeted pill trial aims to control advanced cancers driven by rogue genes

Disease control Terminated

This study tested an experimental pill called futibatinib in people with advanced cancers that have specific changes in genes called FGFR. It enrolled 115 patients into three groups based on their cancer type and specific gene change. The goal was to see if the daily pill could s…

Matched conditions: MYELOID OR LYMPHOID NEOPLASMS (MLN)

Phase: PHASE2 • Sponsor: Taiho Oncology, Inc. • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

MYELOID OR LYMPHOID NEOPLASMS (MLN)

Get alerted when new MYELOID OR LYMPHOID NEOPLASMS (MLN) trials appear

Targeted pill trial aims to control advanced cancers driven by rogue genes